Carnell Clint 4
4 · SOLTA MEDICAL INC · Filed Mar 1, 2011
Insider Transaction Report
Form 4
Carnell Clint
Chief Operating Officer
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2011-02-28−49,999→ 150,001 totalExercise: $1.91Exp: 2020-02-08→ Common Stock (49,999 underlying) - Exercise/Conversion
Common Stock
2011-02-25$1.00/sh+8,570$8,570→ 192,085 total - Exercise/Conversion
Employee Stock Option (right to buy)
2011-02-28−88,930→ 97,500 totalExercise: $1.00Exp: 2019-02-27→ Common Stock (88,930 underlying) - Exercise/Conversion
Common Stock
2011-02-28$1.00/sh+88,930$88,930→ 326,972 total - Exercise/Conversion
Employee Stock Option (right to buy)
2011-02-28−75,332→ 0 totalExercise: $1.90Exp: 2015-10-05→ Common Stock (75,332 underlying) - Sale
Common Stock
2011-02-28$3.16/sh−214,261$677,322→ 162,710 total - Sale
Common Stock
2011-02-25$3.13/sh−75,178$235,307→ 162,710 total - Exercise/Conversion
Common Stock
2011-02-28$1.90/sh+75,332$143,131→ 238,042 total - Exercise/Conversion
Common Stock
2011-02-28$1.91/sh+49,999$95,498→ 376,971 total - Exercise/Conversion
Employee Stock Option (right to buy)
2011-02-25−8,570→ 186,430 totalExercise: $1.00Exp: 2019-02-27→ Common Stock (8,570 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2011-02-25−45,803→ 75,332 totalExercise: $1.90Exp: 2015-10-05→ Common Stock (45,803 underlying) - Exercise/Conversion
Common Stock
2011-02-25$1.90/sh+45,803$87,026→ 237,888 total
Footnotes (5)
- [F1]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $3.10 to $3.18. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $3.10 to $3.25. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold
- [F3]The option becomes exercisable according to the following schedule: 1/48 on 3/31/09 and 1/48 on the last day of each full calendar month thereafter.
- [F4]The option is 100% vested and immediately exercisable.
- [F5]The option becomes exercisable according to the following schedule: 1/48 on March 31, 2010 and 1/48 on the last day of each full calendar month thereafter.